In summary, we identify significant limitations of p16 and p16-driven reporter genes to both identify and remove senescent cells in atherosclerosis, and adverse local or systemic consequences of p16 or ABT-263-mediated senolysis. Here, CDKN2A is linked to atherosclerosis.